Skip to main content

Find Clinical Trials

Home
Conditions
Carcinoma

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,847 public trials 2,102 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma trial results

Completed

Holmium Radioembolization as Adjuvant Treatment to RFA for Early Stage HCC: Dose Finding Study

NCT03437382

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Leiden University Medical Center Leiden, South Holland, Netherlands

View Trial Details

Completed

Next Generation Sequencing of Tumor Cells in Locally Advanced Pancreatic Adenocarcinoma

NCT03578939

Conditions: Adenocarcinoma, Carcinoma, Neoplasms, +2 more
Locations: Istituto Clinico Humanitas Rozzano, Milano, Italy

View Trial Details

Completed

Durvalumab With or Without Tremelimumab in Treating Participants With Stage II-IVA Oropharyngeal Squamous Cell Cancer

NCT03144778

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +8 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Apatinib and Irinotecan Combination Treatment in Esophageal Squamous Cell Carcinoma

NCT02645864

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
Locations: Peking University Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

Phase II Study of Avelumab in Patients With Advanced Hepatocellular Carcinoma After Prior Sorafenib Treatment

NCT03389126

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations: Seoul National University Hospital Seoul, South Korea

View Trial Details

Completed

Observational Study of Correlation Between Recurrent Basal Cell Carcinoma and Localisation

NCT04795297

Conditions: Basal Cell Carcinoma, Carcinoma, Carcinoma, Basal Cell, +4 more
Locations: Uhmontpellier Montpellier, France

View Trial Details

Completed

Intraperitoneal Delivery of Adaptive Natural Killer (NK) Cells (FATE-NK100) With Intraperitoneal Int

NCT03213964

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +25 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

A Phase I, Open-Label, Multicentre Study to Evaluate the Safety, Tolerability and Pharmacokinetics of MEDI4736 in Patients With Advanced Solid Tumours

NCT01938612

Conditions: Advanced Solid Tumors, Biliary Tract Diseases, Biliary Tract Neoplasms, +10 more
Locations: Research Site Beppu-shi, Japan

Research Site Chūōku, Japan

Research Site Kashiwa, Japan

Research Site Kitaadachi-gun, Japan

View all 21 locations

View Trial Details

Completed

An Extension Protocol for Subjects Who Were Previously Enrolled in Other Tivantinib (ARQ 197) Protocols

NCT01178411

Conditions: Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumors, +47 more
Locations: Not specified

View Trial Details

Completed

Study of Gemcitabine+Platinum Salt+Bevacizumab Combination for Metastatic Collecting Duct Carcinoma (GETUG-AFU 24)

NCT02363751

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
Locations: Institut de Cancérologie de l'Ouest-Site Paul Papin Angers, France

CHU Besançon Besançon, France

Hôpital Saint André Bordeaux, France

Centre François Baclesse Caen, France

View all 19 locations

View Trial Details